These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Development of a tolerogenic immune balance and elimination of autoreactive B cells--two important effects of antithymocyte globulin treatment. Söderström T; Olausson M; Blohmé I; Enskog A; Mjörnstedt L; Wramner L; Kjellson B; Brynger H Transplant Proc; 1990 Aug; 22(4):1795-7. PubMed ID: 2117810 [No Abstract] [Full Text] [Related]
8. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion. Klaus G; Mostert K; Reckzeh B; Mueller TF Transplantation; 2003 Dec; 76(12):1719-24. PubMed ID: 14688522 [TBL] [Abstract][Full Text] [Related]
9. Systemic administration of 2-chloro-2'-deoxyadenosine (2-CdA) in patients with systemic scleroderma. Majewski S; Skopińska M; Błaszczyk M; Ryba M; Grieb P; Chorzelski T; Jabłońska S Arch Immunol Ther Exp (Warsz); 1994; 42(1):33-4. PubMed ID: 7503631 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Mahlaoui N; Ouachée-Chardin M; de Saint Basile G; Neven B; Picard C; Blanche S; Fischer A Pediatrics; 2007 Sep; 120(3):e622-8. PubMed ID: 17698967 [TBL] [Abstract][Full Text] [Related]
11. A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders. Gupta V; Gordon-Smith EC; Cook G; Parker A; Duguid JK; Wilson KM; Yi QL; Marsh JC Br J Haematol; 2005 Apr; 129(1):110-7. PubMed ID: 15801963 [TBL] [Abstract][Full Text] [Related]
12. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients. Esposito L; Kamar N; Tkaczuk J; Abbal M; Durand D; Rostaing L Transplant Proc; 2005 Mar; 37(2):785-7. PubMed ID: 15848531 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome. Kaito K; Otsubo H; Takei Y; Usui N; Kobayashi M Ann Hematol; 2003 Nov; 82(11):699-701. PubMed ID: 12961029 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Wieneke H; Otte B; Lang D; Heidenreich S Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of spontaneous E-rosetting by antithymocyte globulin in Graves disease. Balázs C; Leövey A; Sztojka I; Szerze P; Szabó M; Bordán L; Fazakas S Acta Med Acad Sci Hung; 1976; 33(4):333-8. PubMed ID: 1088590 [TBL] [Abstract][Full Text] [Related]
17. The use of antithymocyte globulin in myasthenia gravis. Barnes AD Postgrad Med J; 1976; 52(5 Suppl):110-1. PubMed ID: 1087016 [TBL] [Abstract][Full Text] [Related]
18. Effect of highly active anti-retroviral therapy on CD3+/CD4+/CD8+ T lymphocyte counts in HIV seropositive Kashmiri patients: a follow up study. Shah ZA; Rasool R; Siddiqi MA Indian J Pathol Microbiol; 2007 Jul; 50(3):648-51. PubMed ID: 17883172 [TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia. Chen JS; Li LS; Cheng DR; Ji SM; Sun QQ; Cheng Z; Wen JQ; Sha GZ; Liu ZH Transplant Proc; 2009 Jun; 41(5):1639-42. PubMed ID: 19545698 [TBL] [Abstract][Full Text] [Related]